After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
A new randomized clinical trial from investigators at Mass General Brigham’s Neuroscience Institute and Department of ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of ...
The products are far from a proven sleep treatment.
High-dose DHA effectively increased brain levels in older adults at Alzheimer's risk, but did not lead to cognitive or ...
A new University of Georgia network meta-analysis finds tirzepatide sitting at the top of the weight-loss heap among commonly ...
Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
Background Difference-in-differences is a method commonly used in population health research. It is based on assumptions that ...
Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results